DXR
Daxor Corporation
NASDAQ: DXR · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$10.17
-4.39% today
Updated 2026-06-05
Market cap
$61.88M
P/E ratio
6.46
P/S ratio
2,318.84x
EPS (TTM)
$1.64
Dividend yield
—
52W range
$8 – $15
Volume
0.0M
Daxor Corporation (DXR) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$10.17
12-Month target
$12.61
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 6.46x (capped 25x) · Margin: 34,359.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.